| Literature DB >> 35302258 |
Sajjad Chamani1,2, Maryam Moossavi3, Ali Naghizadeh1, Mitra Abbasifard4,5, Muhammed Majeed6, Thomas P Johnston7, Amirhossein Sahebkar8,9,10,11.
Abstract
Systemic autoimmune diseases like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus represent various autoimmune conditions identified by immune system dysregulation. The activation of immune cells, auto-antigen outbreak, inflammation, and multi-organ impairment is observed in these disorders. The immune system is an essential complex network of cells and chemical mediators which defends the organism's integrity against foreign microorganisms, and its precise operation and stability are compulsory to avoid a wide range of medical complications. Curcumin is a phenolic ingredient extracted from turmeric and belongs to the Zingiberaceae, or ginger family. Curcumin has multiple functions, such as inhibiting inflammation, oxidative stress, tumor cell proliferation, cell death, and infection. Nevertheless, the immunomodulatory influence of curcumin on immunological reactions/processes remains mostly unknown. In the present narrative review, we sought to provide current information concerning the preclinical and clinical uses of curcumin in systemic autoimmune diseases.Entities:
Keywords: curcumin; immunomodulatory effect; inflammation; systemic autoimmune diseases
Mesh:
Substances:
Year: 2022 PMID: 35302258 DOI: 10.1002/ptr.7417
Source DB: PubMed Journal: Phytother Res ISSN: 0951-418X Impact factor: 5.878